Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer

Introduction Autoantibodies against inflammatory cytokines may be used for the prevention of atherosclerosis. Preclinical studies consider colony-stimulating factor 2 (CSF2) as an essential cytokine with a causal relationship to atherosclerosis and cancer. We examined the serum anti-CSF2 antibody levels in patients with atherosclerosis or solid cancer. Methods We measured the serum anti-CSF2 antibody levels via amplified luminescent proximity homogeneous assay-linked immunosorbent assay based on the recognition of recombinant glutathione S-transferase-fused CSF2 protein or a CSF2-derived peptide as the antigen. Results The serum anti-CSF2 antibody (s-CSF2-Ab) levels were significantly higher in patients with acute ischemic stroke (AIS), acute myocardial infarction (AMI), diabetes mellitus (DM), and chronic kidney disease (CKD) compared with healthy donors (HDs). In addition, the s-CSF2-Ab levels were associated with intima-media thickness and hypertension. The analyzes of samples obtained from a Japan Public Health Center-based prospective study suggested the utility of s-CSF2-Ab as a risk factor for AIS. Furthermore, the s-CSF2-Ab levels were higher in patients with esophageal, colorectal, gastric, and lung cancer than in HDs but not in those with mammary cancer. In addition, the s-CSF2-Ab levels were associated with unfavorable postoperative prognosis in colorectal cancer (CRC). In CRC, the s-CSF2-Ab levels were more closely associated with poor prognosis in patients with p53-Ab-negative CRC despite the lack of significant association of the anti-p53 antibody (p53-Ab) levels with the overall survival. Conclusion S-CSF2-Ab was useful for the diagnosis of atherosclerosis-related AIS, AMI, DM, and CKD and could discriminate poor prognosis, especially in p53-Ab-negative CRC.

[1]  Y. Iwadate,et al.  Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction , 2021, Scientific Reports.

[2]  H. Shimada,et al.  Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers. , 2021, Molecular and clinical oncology.

[3]  G. Malviya,et al.  Role of Peptides in Diagnostics , 2021, International journal of molecular sciences.

[4]  M. Kunimatsu,et al.  Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke , 2021, BMC Medicine.

[5]  J. Stone,et al.  Neutralizing Anti-Interleukin-1 Receptor-Antagonist Autoantibodies Induce Inflammatory and Fibrotic Mediators in IgG4-Related Disease. , 2021, The Journal of allergy and clinical immunology.

[6]  S. Tsugane,et al.  Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis , 2021, Scientific Reports.

[7]  W. Fitzgerald,et al.  Differential clusterization of soluble and extracellular vesicle-associated cytokines in myocardial infarction , 2020, Scientific Reports.

[8]  Rika Nakamura,et al.  Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases , 2020, Heliyon.

[9]  Jiang Li,et al.  Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension , 2020, International journal of molecular medicine.

[10]  H. Nagai,et al.  CA19-9 is a significant prognostic marker of patients with stage III gastric cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  A. Levine.  P53 and The Immune Response: 40 Years of Exploration—A Plan for the Future , 2020, International journal of molecular sciences.

[12]  大腸癌研究会.  Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication] , 2019, Journal of the anus, rectum and colon.

[13]  Yuan Yuan,et al.  p53 protein expression affected by TP53 polymorphism is associated with the biological behavior and prognosis of low rectal cancer. , 2019, Oncology letters.

[14]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[15]  M. Sánchez-Niño,et al.  Atherosclerosis in Chronic Kidney Disease. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Shixiong Deng,et al.  Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer , 2019, Cancer Cell International.

[17]  O. Sabry,et al.  Granulocyte Macrophage Colony Stimulating Factor as an Adjuvant in ESRD at High Risk of Bacterial Infection , 2018, Journal of Medical Sciences.

[18]  M. Takiguchi,et al.  Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis , 2018, Journal of Neuroimmunology.

[19]  Daishi Tian,et al.  Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1/6 pathway , 2018, Theranostics.

[20]  K. Hayashi,et al.  Additive Prognostic Value of Carotid Plaque Score to Enhance the Age, Creatinine, and Ejection Fraction Score in Patients with Acute Coronary Syndrome , 2018, Journal of atherosclerosis and thrombosis.

[21]  Aladeen Alloubani,et al.  Hypertension and diabetes mellitus as a predictive risk factors for stroke. , 2018, Diabetes & metabolic syndrome.

[22]  L. Germain,et al.  Enhanced wound healing of tissue-engineered human corneas through altered phosphorylation of the CREB and AKT signal transduction pathways. , 2018, Acta biomaterialia.

[23]  T. Ozaki,et al.  Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea , 2018, PloS one.

[24]  H. Matsubara,et al.  Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library , 2018, Oncotarget.

[25]  Takeshi Kimura,et al.  Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction , 2017, Oncotarget.

[26]  Rika Nakamura,et al.  Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack , 2017, Oncotarget.

[27]  Correction to: 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2018, Stroke.

[28]  S. Ghosh,et al.  Studying in vitro phagocytosis of apoptotic cancer cells by recombinant GMCSF-treated RAW 264.7 macrophages. , 2017, International journal of biological macromolecules.

[29]  X. Qin,et al.  Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy , 2017, Oncology letters.

[30]  S. Kapadia,et al.  Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke. , 2017, The American journal of cardiology.

[31]  J. Xie,et al.  Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer , 2017, OncoTargets and therapy.

[32]  Takeshi Kimura,et al.  Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. , 2016, International journal of cardiology.

[33]  P. Yu,et al.  The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms , 2016, Oncogene.

[34]  Y. Hashiguchi,et al.  Serum carcinoembryonic antigen as a tumour marker in patients with endometrial cancer. , 2016, Current oncology.

[35]  I. Hong.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types , 2016, Experimental & Molecular Medicine.

[36]  Ping Yang,et al.  HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas , 2016, Oncotarget.

[37]  H. Scharnagl,et al.  Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect , 2016, PloS one.

[38]  H. Doi,et al.  Elevated Levels of Autoantibodies against ATP2B4 and BMP-1 in Sera of Patients with Atherosclerosis-related Diseases , 2015 .

[39]  F. Sallusto,et al.  Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis , 2015, Nature Communications.

[40]  I. Jacobs,et al.  Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples , 2015, British Journal of Cancer.

[41]  Raynoo Thanan,et al.  Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer , 2014, International journal of molecular sciences.

[42]  S. Tsugane,et al.  The JPHC study: design and some findings on the typical Japanese diet. , 2014, Japanese journal of clinical oncology.

[43]  S. Browne.  Anticytokine autoantibody-associated immunodeficiency. , 2014, Annual review of immunology.

[44]  M. Atabek,et al.  Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients. , 2014, Journal of diabetes and its complications.

[45]  N. Hadi,et al.  Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches , 2013, BioMed research international.

[46]  Yuwen Li,et al.  Abstract 15: Loss of Tumor Suppressor Protein p53 is linked to High Blood Pressure , 2013, Hypertension.

[47]  M. Inoue,et al.  The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study. , 2013, Atherosclerosis.

[48]  R. Lothe,et al.  Epigenetic and genetic features of 24 colon cancer cell lines , 2013, Oncogenesis.

[49]  C. Tanase,et al.  Cytokine Patterns in Brain Tumour Progression , 2013, Mediators of inflammation.

[50]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[51]  M. Fraga,et al.  Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. , 2013, Cancer Research.

[52]  T. Lehtimäki,et al.  Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. , 2012, Atherosclerosis.

[53]  R. P. Kleyweg,et al.  [Initial reactions of patients after a stroke: more than half undertake no action]. , 2012, Nederlands tijdschrift voor geneeskunde.

[54]  Hye-Jin Park,et al.  Is the carotid intima-media thickness really a good surrogate marker of atherosclerosis? , 2012, Journal of atherosclerosis and thrombosis.

[55]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[56]  S. Holland,et al.  Immunodeficiency secondary to anticytokine autoantibodies , 2010, Current opinion in allergy and clinical immunology.

[57]  E. Yu,et al.  Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  J. Mehta,et al.  Cardiac Hypertrophy During Hypercholesterolemia and Its Amelioration With Rosuvastatin and Amlodipine , 2009, Journal of cardiovascular pharmacology.

[59]  Nobuyuki Taniguchi,et al.  Standard method for ultrasound evaluation of carotid artery lesions , 2009, Journal of Medical Ultrasonics.

[60]  Y. Iwadate,et al.  Activation of NFAT signal by p53‐K120R mutant , 2009, FEBS letters.

[61]  K. Kitamura,et al.  Recent Therapeutic Strategies Improve Renal Outcome in Patients with IgA Nephropathy , 2009, American Journal of Nephrology.

[62]  K. Kitamura,et al.  Elevated Osteoprotegerin Levels Predict Cardiovascular Events in New Hemodialysis Patients , 2008, American Journal of Nephrology.

[63]  M. Dianzani,et al.  Lipid peroxidation: control of cell proliferation, cell differentiation and cell death. , 2008, Molecular aspects of medicine.

[64]  Takanobu Tomaru,et al.  Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[65]  S. Gutnikov,et al.  Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison , 2007, The Lancet.

[66]  K. Vousden,et al.  Ubiquitination and Degradation of Mutant p53 , 2007, Molecular and Cellular Biology.

[67]  F. Guadagni,et al.  Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma. , 2007, The International journal of biological markers.

[68]  B. Toh,et al.  GM-CSF Deficiency Reduces Macrophage PPAR-&ggr; Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[69]  Klaus Heese,et al.  The Bad Guy Cooperates with Good Cop p53: Bad Is Transcriptionally Up-Regulated by p53 and Forms a Bad/p53 Complex at the Mitochondria To Induce Apoptosis , 2006, Molecular and Cellular Biology.

[70]  Kuniaki Otsuka,et al.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). , 2006, Journal of atherosclerosis and thrombosis.

[71]  M. Oka,et al.  Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-κB p65 in esophageal carcinoma cells: possible involvement of Fas/Fas-L synergism , 2006, Apoptosis.

[72]  P. Grenier,et al.  Tumor Antigen Markers for the Detection of Solid Cancers in Inflammatory Myopathies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[73]  P. Rothwell,et al.  Timing of TIAs preceding stroke , 2005, Neurology.

[74]  M. Agarwal,et al.  In vivo Recombinant Adenovirus-mediated p53 Gene Therapy in a Syngeneic Rat Model for Colorectal Cancer , 2004, Journal of Korean medical science.

[75]  L. Chan,et al.  Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[76]  D. Hanley,et al.  Prevalence and knowledge of transient ischemic attack among US adults , 2003, Neurology.

[77]  H. Shimada,et al.  Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. , 2003, Cancer.

[78]  Y. Aude,et al.  Nonplatelet-mediated effects of aspirin. , 2002, Drugs of today.

[79]  J. Whitsett,et al.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. , 2001, Immunity.

[80]  T. V. van Berkel,et al.  Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice , 2001, Circulation research.

[81]  L. Parker,et al.  Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. , 2000, Annals of clinical and laboratory science.

[82]  P Ducimetière,et al.  Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[83]  K. Nakazato,et al.  Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits. , 1999, Circulation.

[84]  E. I. Antonova,et al.  The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo , 1999, Nature Medicine.

[85]  T. Tsuruo,et al.  5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. , 1998, British Journal of Cancer.

[86]  M. Arima,et al.  Detection of Serum p53 Antibodies in Mucosal Esophageal Cancer and Negative Conversion After Treatment , 1998, American Journal of Gastroenterology.

[87]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[88]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[89]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[90]  K. Westbrook,et al.  Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. , 1991, Archives of surgery.

[91]  K Kimura,et al.  Ultrasonic evaluation of early carotid atherosclerosis. , 1990, Stroke.

[92]  K. Yabuta,et al.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.

[93]  J. Neaton,et al.  Blood Pressure (Systolic and Diastolic) and Risk of Fatal Coronary Heart Disease , 1989, Hypertension.

[94]  S B Hulley,et al.  Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. , 1986, American heart journal.

[95]  J. Palmer,et al.  Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.

[96]  W. Hollander,et al.  Role of hypertension in atherosclerosis and cardiovascular disease. , 1976, The American journal of cardiology.